Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04901897 · ClinicalTrials.gov registry record · NA
Product Performance of a New Silicone Hydrogel Contact Lens
A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 805
- Enrollment target
- 20
- Study locations
NCT04901897: Completed NA study of Myopia, sponsored by Bausch & Lomb Incorporated.
NCT04901897 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 805 participants, above the 259-participant average among 90 other Myopia trials with a reported enrollment target (211% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04901897, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 805 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to evaluate the product performance of kalifilcon A, compared to the Johnson \& Johnson Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens and Alcon DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses when worn by current soft contact lens wearers on a daily disposable wear basis.
Primary Outcome
logMAR is the logarithm of the minim angle of resolution
Conditions Studied
Interventions
- DEVICE senofilcon A
- DEVICE delefilcon A
- DEVICE kalifilcon A
Study Locations (20)
California
- Bausch Site 406 - Azusa
- Bausch Site 430 - Los Angeles
- Bausch Site 419 - San Diego
- Bausch Site 435 - San Francisco
- Bausch Site 432 - Sunnyvale
- Bausch Site 409 - Torrance
Florida
- Bausch Site 415 - Jacksonville
- Bausch Site 434 - Jacksonville
- Bausch Site 405 - Sarasota
Hawaii
- Bausch Site 437 - Honolulu
- Bausch Site 401 - ‘Aiea
Alabama
- Bausch Site 433 - Birmingham
Arizona
- Bausch Site 431 - Scottsdale
Colorado
- Bausch Site 416 - Denver
Georgia
- Bausch Site 412 - Decatur
Kansas
- Bausch Site 414 - Leavenworth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 805 participants |
| Start Date | 2019-07-31 |
| Est. Completion | 2019-10-09 |
| Phase | NA |
What the finished NCT04901897 record still lists
NCT04901897 is an interventional study that assigns participants to a tested intervention. The registered 805 participants enrollment target is mid-sized for trials with a published cap, above the 259-participant average among 90 other Myopia trials with a reported enrollment target (211% higher).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 3 interventions - of which senofilcon A is the first listed.
NCT04901897 names 20 study sites across 12 states, led by California, Florida, Hawaii.
Frequently Asked Questions
What is clinical trial NCT04901897 about?
NCT04901897 is a clinical study titled "Product Performance of a New Silicone Hydrogel Contact Lens". The objective of this study is to evaluate the product performance of kalifilcon A, compared to the Johnson \& Johnson Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens and Alcon DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses when worn by current soft c...
What is the current status of trial NCT04901897?
This trial is currently completed. It is a NA study. The enrollment target is 805 participants. The study started on 2019-07-31. Estimated completion is 2019-10-09.
What conditions does trial NCT04901897 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT04901897?
The interventions under investigation include: senofilcon A (DEVICE), delefilcon A (DEVICE), kalifilcon A (DEVICE).
Who is sponsoring clinical trial NCT04901897?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04901897 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04901897's enrollment target sits among peer trials
805 6th of 90 higher than 85 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI